Synthesis and Biological Evaluation of New GnRH Analogues on Pituitary and Breast Cancer Cells
- 12 December 2006
- journal article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 13 (1-2) , 143-149
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- GnRH analogues containing conformationally restricted amino acids in positions 3 and 6: differential impact on pituitary binding affinity and direct antiproliferative effect on breast cancer cells†Chemical Biology & Drug Design, 2005
- Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP‐2 and MMP‐9) by human epithelial breast cancer cellsInternational Journal of Cancer, 2003
- Gonadotropin-releasing-hormone-receptor antagonistsThe Lancet, 2001
- Molecular Mechanisms of Ligand Interaction with the Gonadotropin-Releasing Hormone ReceptorEndocrine Reviews, 1997
- The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitaryMolecular and Cellular Endocrinology, 1994
- Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancerJournal of Clinical Laboratory Analysis, 1989
- Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cellsEuropean Journal of Cancer and Clinical Oncology, 1985
- Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonistNature, 1985
- Structure-activity relationships in the C-terminal part of luteinizing hormone releasing hormone (LH-RH)Biochemical and Biophysical Research Communications, 1972
- Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine originBiochemical and Biophysical Research Communications, 1971